| |
Note |
20041 |
2005 |
| EUR million |
|
|
|
| Operating result [EBIT] |
|
1,875 |
2,812 |
| Income taxes |
|
(490) |
(541) |
| Depreciation and amortization |
|
1,959 |
1,835 |
| Change in pension provisions |
|
(424) |
(586) |
| (Gains) losses on retirements of noncurrent
assets |
|
(35) |
(43) |
| Gross cash flow2 |
|
2,885 |
3,477 |
| |
|
|
|
| Decrease (increase) in inventories |
|
(425) |
(181) |
| Decrease (increase) in trade accounts
receivable |
|
(404) |
156 |
| (Decrease) increase in trade accounts
payable |
|
(5) |
(115) |
| Changes in other working capital, other
non-cash items |
|
211 |
205 |
Net cash provided by (used in) operating
activities
(net cash flow, continuing operations) |
[36] |
2,262 |
3,542 |
Net cash provided by (used in) operating
activities
(net cash flow, discontinued operations) |
[7.2] |
188 |
(40) |
Net cash provided by (used in)
operating activities
(net cash flow, total) |
|
2,450 |
3,502 |
| |
|
|
|
Cash outflows for additions to property,
plant,
equipment and intangible assets |
|
(1,251) |
(1,389) |
| Cash inflows from sales of property,
plant, equipment and other assets |
|
200 |
398 |
| Cash inflows from sales of investments |
|
90 |
1,189 |
| Cash outflows for acquisitions less acquired
cash |
|
(358) |
(2,188) |
| Interest and dividends received |
|
400 |
451 |
| Cash inflows from (outflows for) marketable
securities |
|
105 |
(202) |
| Net cash provided by (used in) investing
activities (total) |
[37] |
(814) |
(1,741) |
| |
|
|
|
| Capital contributions |
|
10 |
0 |
| Bayer AG dividend and dividend payments
to minority stockholders |
|
(559) |
(440) |
| Issuances of debt |
|
1,393 |
2,005 |
| Retirements of debt |
|
(881) |
(2,659) |
| Interest paid |
|
(724) |
(787) |
| Net cash provided by (used in) financing
activities (total) |
[38] |
(761) |
(1,881) |
| |
|
|
|
| Change in cash and cash equivalents due
to business activities (total) |
|
875 |
(120) |
| |
|
|
|
| Cash and cash equivalents at
beginning of year |
|
2,734 |
3,570 |
| |
|
|
|
Change in cash and cash equivalents due
to
changes in scope of consolidation |
|
6 |
(196) |
| Change in cash and cash equivalents due
to exchange rate movements |
|
(45) |
36 |
| |
|
|
|
| Cash and cash equivalents at end of year |
[39] |
3,570 |
3,290 |
| |
|
|
|
| Marketable securities and other instruments |
|
29 |
233 |
| |
|
|
|
| Liquid assets as per balance
sheets |
|
3,599 |
3,523 |
top
E-mail this page
Download Acrobat Reader